Error loading player: No playable sources found

  To view this video content in its entirety, click on the "Access Content" button and login to your account.

If you do not have an account, register for free.

Please note that the account you create here is different than your Keystone Symposia account at www.keystonesymposia.org used to register for our multi-day conferences and is uniquely for viewing our virtual content.


Tech Transfer for Medical Advances: Challenges and Opportunities in Commercializing Academic Biomedical Research

Date
February 14, 2018
Free
Standard Price
This product is also available as part of the following products:

The pharmaceutical industry needs access to innovation from academia to develop new drugs, and academic institutions are more interested than ever in finding a commercial route for their discoveries. However, the process whereby an academic discovery gives rise to a new medicine is too complex and inefficient. What are the obstacles that result in such inefficiency? How can we overcome these challenges? The goal of this Virtual Keystone Symposium is to tackle these challenges and identify potential solutions.

 

To that end, we will convene experts in various aspects of science commercialization — academic entrepreneurs, technology-transfer specialists, venture investors, pharma scientists — who routinely interact with academic scientists to discuss issues such as the key considerations when deciding what project to commercialize; how academic institutions can learn more about what investors or pharma look for when they scout for projects; what the biggest obstacles are for investors when interacting with academic institutions; and other related questions.

Event Hashtag: #VKStechtransfer

Moderator

Speaker Image for Juan Carlos López
Founder, Haystack Science

Panelists

Speaker Image for Lita  Nelsen
Director - Retired, MIT Technology Licensing Office
Speaker Image for Curtis Keith
Harvard University
Speaker Image for Katherine Bowdish
Sunrise Ventures Sanofi
Speaker Image for Avi   Spier
Novartis Institutes of Biomedical Research

Related Products

Thumbnail for Health Disparities: Sickle Cell, Research and CRISPR
Health Disparities: Sickle Cell, Research and CRISPR
About 100,000 people in the United States have sickle cell disease, with most of the patient population derived from communities of African descent…
Thumbnail for Digital Health: From Science to Application
Digital Health: From Science to Application
The increased use of smartphones, devices and digital sensors is rapidly becoming a universal part of everyday life for populations around the world…
Thumbnail for  Health Disparities: The Intersection of Science and Race
Health Disparities: The Intersection of Science and Race
Forty years ago, the infamous Tuskegee syphilis trials called attention to the disparate treatment of underrepresented (UR) populations in the U.S., prompting a major overhaul of the U.S. public healthcare system…
Thumbnail for Rigor in Science: The Challenge of Reproducibility in Biomedical Research
Rigor in Science: The Challenge of Reproducibility in Biomedical Research
Every researcher has a story about a compelling result that didn’t reproduce. Sometimes this is due to technical challenges or the experimental approach…
Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.